Patents by Inventor Jaroslava SVOBODOVA

Jaroslava SVOBODOVA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical composition comprising rosuvastatin and ezetimibe and a preparation method thereof
    Patent number: 11786526
    Abstract: The invention relates to a pharmaceutical composition comprising the active ingredients rosuvastatin of formula I, with the systematic name (3R,5S,6E)-7-[4-(4-fluorophenyl)-2-(N-methylmethanesulfonamido)-6-(propan-2-yl)pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid or its pharmaceutically acceptable salts, esters, hydrates or solvates, and ezetimibe of formula II, with the systematic name (3R,4S)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)azetidin-2-one or its pharmaceutically acceptable salts, esters, hydrates or solvates, as well as a preparation method of this pharmaceutical composition. The weight ratio of the layers is 1:2 to 2:1.
    Type: Grant
    Filed: August 31, 2017
    Date of Patent: October 17, 2023
    Assignee: SANOFI
    Inventors: Alena Prokopova, Jaroslava Svobodova, Ondrej Dammer, Petr Mikes
  • A PHARMACEUTICAL COMPOSITION COMPRISING ROSUVASTATIN AND EZETIMIBE AND A PREPARATION METHOD THEREOF
    Publication number: 20200009136
    Abstract: The invention relates to a pharmaceutical composition comprising the active ingredients rosuvastatin of formula I, with the systematic name (3R,5S,6E)-7-[4-(4-fluorophenyl)-2-(N-methylmethanesulfonamido)-6-(propan-2-yl)pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid or its pharmaceutically acceptable salts, esters, hydrates or solvates, and ezetimibe of formula II, with the systematic name (3R,4S)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)azetidin-2-one or its pharmaceutically acceptable salts, esters, hydrates or solvates, as well as a preparation method of this pharmaceutical composition. The weight ratio of the layers is 1:2 to 2:1.
    Type: Application
    Filed: August 31, 2017
    Publication date: January 9, 2020
    Inventors: Alena PROKOPOVA, Jaroslava SVOBODOVA, Ondrej DAMMER, Petr MIKES